Top Institutions in Allergy and Immunology
Leading academic medical centers with strong allergy and immunology research programs and clinical trial infrastructures have conducted pivotal phase III trials evaluating dupilumab in CSU, leveraging multicenter, randomized, double-blind, placebo-controlled designs to establish efficacy and safety.
-
#1
National Institute of Allergy and Infectious Diseases (NIAID), NIH
Bethesda, MD
NIAID leads in immunologic research and clinical trials for allergic diseases including chronic urticaria, with extensive experience in biologic therapies and large-scale multicenter studies.
Key Differentiators
- Allergy and Immunology
- Clinical Trials
- Immunotherapy
-
#2
Mayo Clinic
Rochester, MN
Mayo Clinic has a robust allergy and immunology division with expertise in chronic urticaria management and participation in clinical trials evaluating novel biologics like dupilumab.
Key Differentiators
- Allergy and Immunology
- Dermatology
- Clinical Research
-
#3
Johns Hopkins University School of Medicine
Baltimore, MD
Johns Hopkins has a leading allergy and clinical immunology program with a focus on translational research in chronic urticaria and biologic treatments.
Key Differentiators
- Allergy and Immunology
- Clinical Immunology
- Translational Research
-
#4
Massachusetts General Hospital
Boston, MA
MGH has a strong clinical trials program in allergy and dermatology, contributing to research on novel therapies for chronic spontaneous urticaria including biologics.
Key Differentiators
- Allergy and Immunology
- Dermatology
- Clinical Trials
-
#5
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
Penn Medicine has a dedicated allergy and immunology division with active involvement in clinical trials and research on biologic agents for chronic urticaria.
Key Differentiators
- Allergy and Immunology
- Clinical Research
- Immunotherapy
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
